A speaker addressing a conference audience

A Clear Path from Ideas to Impact

The ASPS Innovation Ecosystem

ASPS has built a structured, end-to-end pipeline for identifying, validating, and investing in plastic surgery innovation — one that starts inside a global community of more than 11,000 surgeons and ends in funded portfolio companies.

1

A Global Community of Expertise

Plastic Surgery Community (~11,000+ surgeons globally)

Our community is the foundation — a constant source of clinical insight, real-world experience, and unmet needs.

2

Innovation Sourcing

Ideas and opportunities come from across the ASPS community.

Inventors Challenge

Surfaces early-stage companies and innovations led by surgeons, residents, and students from across the community.

Hot Topics Symposium

A technology showcase for emerging devices and platforms, run in tandem with MTI cohort presentations.

MedTech Innovator – Plastic Surgery Track

~100 companies screened annually, narrowed to 12 finalists who pitch, with 5 ultimately joining the cohort.

3

Structure

Ongoing support to validate and advance the most promising innovations.

TIDE Committee

Provides strategic oversight of innovation, staying engaged with emerging technologies on a monthly basis.

LIFTT Platform

Connects companies to clinical insight and development support — KOL access, trial design, and market validation.

Investment Opportunity Zone

Vetted innovations move forward for potential investment.

4

Capital

Targeted investment to accelerate promising companies.

SPV Program

Selective investments built on an early partnership model with the most promising companies.

ASPS Venture Fund (Planned)

A diversified portfolio built on a co-GP structure, designed for broader, longer-term capital deployment.

5

From Portfolio to Progress

Backed companies advance toward meaningful impact.

Portfolio Companies

Innovative solutions move through our pipeline.

Strategic MedTech Exits

Successful companies create value for patients, surgeons, and investors.

ASPS × MedTech Innovator Accelerator

Clinical Validation. Measurable Impact.

Combined outcomes from the 23 companies selected for the ASPS plastic surgery track of the MedTech Innovator competition since 2022.

150+Patents Issued
100+Peer-Reviewed Publications
29+Human Studies
50+Animal Studies
23+Products Launched
$337,500+MTI Competition Funding
$160M+Total Capital Raised
2Exits / Acquisitions

Current 2026 Cohort

2026 MTI Cohort
Genesis Tissue
2026 MTI Cohort
GenAssist
2026 MTI Cohort
Feminai
2026 MTI Cohort
Tissuelock
2026 MTI Cohort
ImageAssist

Previous Cohorts

2025

Alumni
MEDCu
Alumni
Brij Medical
Alumni
inSomaBio
Alumni
Regenyx
Alumni
Entirety Biomedical

2024

Alumni
R Bio
Alumni
Akeyna
Alumni
fasciotens
Alumni
Lattice Medical
Alumni
Avance Innovations

2023

Alumni
Newrotex
Alumni
ImmersiveTouch
Alumni
4D EMR
Alumni
Fingy3D
Alumni
Cellulora

2022

Alumni
Suturegard Medical
Alumni
LimaxBio
Alumni
Ad Vital